Glutamate receptor genetic variants affected peripheral glutamatergic transmission and treatment induced improvement of Indian ADHD probands

Attention deficit hyperactivity disorder (ADHD), a childhood-onset neurobehavioral disorder, often perturbs scholastic achievement and peer-relationship. The pivotal role of glutamate (Glu) in learning and memory indicated an influence of Glu in ADHD, leading to the exploration of Glu in different b...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 13; no. 1; pp. 19922 - 14
Main Authors Chatterjee, Mahasweta, Saha, Sharmistha, Shom, Sayanti, Dutta, Nilanjana, Sinha, Swagata, Mukhopadhyay, Kanchan
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 14.11.2023
Nature Publishing Group
Nature Portfolio
Subjects
631/208
631/337
631/378
631/61
692/308
692/4017
692/53
692/699
Attention deficit hyperactivity disorder
Children
Gene expression
Genetic diversity
Genetic variance
Genotypes
Glutamate receptors
Glutamatergic transmission
Humanities and Social Sciences
Methylphenidate
multidisciplinary
Peripheral blood
Science
Science (multidisciplinary)
Online AccessGet full text

Cover

Abstract Attention deficit hyperactivity disorder (ADHD), a childhood-onset neurobehavioral disorder, often perturbs scholastic achievement and peer-relationship. The pivotal role of glutamate (Glu) in learning and memory indicated an influence of Glu in ADHD, leading to the exploration of Glu in different brain regions of ADHD subjects. We for the first time analyzed GluR genetic variations, Glu levels, as well as expression of Glu receptors (GluR) in the peripheral blood of eastern Indian ADHD probands to find out the relevance of Glu in ADHD prognosis. After obtaining informed written consent for participation, peripheral blood was collected for analyzing the genetic variants, Glu level, and expression of target genes. Since ADHD probands are often treated with methylphenidate or atomoxetine for providing symptomatic remediation, we have also tested post-therapeutic improvement in the ADHD trait scores in the presence of different GluR genotypes. Two variants, GRM7 rs3749380 “T” and GRIA1 rs2195450 “C”, exhibited associations with ADHD (P ≤ 0.05). A few GluR genetic variants showed significant association with higher trait severity, low IQ, lower plasma Glu level, down-regulated GluR mRNA expression, and poor response to medications. This indicates that down-regulated glutamatergic system may have an effect on ADHD etiology and treatment efficacy warranting further in-depth investigation.
AbstractList Attention deficit hyperactivity disorder (ADHD), a childhood-onset neurobehavioral disorder, often perturbs scholastic achievement and peer-relationship. The pivotal role of glutamate (Glu) in learning and memory indicated an influence of Glu in ADHD, leading to the exploration of Glu in different brain regions of ADHD subjects. We for the first time analyzed GluR genetic variations, Glu levels, as well as expression of Glu receptors (GluR) in the peripheral blood of eastern Indian ADHD probands to find out the relevance of Glu in ADHD prognosis. After obtaining informed written consent for participation, peripheral blood was collected for analyzing the genetic variants, Glu level, and expression of target genes. Since ADHD probands are often treated with methylphenidate or atomoxetine for providing symptomatic remediation, we have also tested post-therapeutic improvement in the ADHD trait scores in the presence of different GluR genotypes. Two variants, GRM7 rs3749380 “T” and GRIA1 rs2195450 “C”, exhibited associations with ADHD (P ≤ 0.05). A few GluR genetic variants showed significant association with higher trait severity, low IQ, lower plasma Glu level, down-regulated GluR mRNA expression, and poor response to medications. This indicates that down-regulated glutamatergic system may have an effect on ADHD etiology and treatment efficacy warranting further in-depth investigation.
Attention deficit hyperactivity disorder (ADHD), a childhood-onset neurobehavioral disorder, often perturbs scholastic achievement and peer-relationship. The pivotal role of glutamate (Glu) in learning and memory indicated an influence of Glu in ADHD, leading to the exploration of Glu in different brain regions of ADHD subjects. We for the first time analyzed GluR genetic variations, Glu levels, as well as expression of Glu receptors (GluR) in the peripheral blood of eastern Indian ADHD probands to find out the relevance of Glu in ADHD prognosis. After obtaining informed written consent for participation, peripheral blood was collected for analyzing the genetic variants, Glu level, and expression of target genes. Since ADHD probands are often treated with methylphenidate or atomoxetine for providing symptomatic remediation, we have also tested post-therapeutic improvement in the ADHD trait scores in the presence of different GluR genotypes. Two variants, GRM7 rs3749380 "T" and GRIA1 rs2195450 "C", exhibited associations with ADHD (P ≤ 0.05). A few GluR genetic variants showed significant association with higher trait severity, low IQ, lower plasma Glu level, down-regulated GluR mRNA expression, and poor response to medications. This indicates that down-regulated glutamatergic system may have an effect on ADHD etiology and treatment efficacy warranting further in-depth investigation.Attention deficit hyperactivity disorder (ADHD), a childhood-onset neurobehavioral disorder, often perturbs scholastic achievement and peer-relationship. The pivotal role of glutamate (Glu) in learning and memory indicated an influence of Glu in ADHD, leading to the exploration of Glu in different brain regions of ADHD subjects. We for the first time analyzed GluR genetic variations, Glu levels, as well as expression of Glu receptors (GluR) in the peripheral blood of eastern Indian ADHD probands to find out the relevance of Glu in ADHD prognosis. After obtaining informed written consent for participation, peripheral blood was collected for analyzing the genetic variants, Glu level, and expression of target genes. Since ADHD probands are often treated with methylphenidate or atomoxetine for providing symptomatic remediation, we have also tested post-therapeutic improvement in the ADHD trait scores in the presence of different GluR genotypes. Two variants, GRM7 rs3749380 "T" and GRIA1 rs2195450 "C", exhibited associations with ADHD (P ≤ 0.05). A few GluR genetic variants showed significant association with higher trait severity, low IQ, lower plasma Glu level, down-regulated GluR mRNA expression, and poor response to medications. This indicates that down-regulated glutamatergic system may have an effect on ADHD etiology and treatment efficacy warranting further in-depth investigation.
Abstract Attention deficit hyperactivity disorder (ADHD), a childhood-onset neurobehavioral disorder, often perturbs scholastic achievement and peer-relationship. The pivotal role of glutamate (Glu) in learning and memory indicated an influence of Glu in ADHD, leading to the exploration of Glu in different brain regions of ADHD subjects. We for the first time analyzed GluR genetic variations, Glu levels, as well as expression of Glu receptors (GluR) in the peripheral blood of eastern Indian ADHD probands to find out the relevance of Glu in ADHD prognosis. After obtaining informed written consent for participation, peripheral blood was collected for analyzing the genetic variants, Glu level, and expression of target genes. Since ADHD probands are often treated with methylphenidate or atomoxetine for providing symptomatic remediation, we have also tested post-therapeutic improvement in the ADHD trait scores in the presence of different GluR genotypes. Two variants, GRM7 rs3749380 “T” and GRIA1 rs2195450 “C”, exhibited associations with ADHD (P ≤ 0.05). A few GluR genetic variants showed significant association with higher trait severity, low IQ, lower plasma Glu level, down-regulated GluR mRNA expression, and poor response to medications. This indicates that down-regulated glutamatergic system may have an effect on ADHD etiology and treatment efficacy warranting further in-depth investigation.
ArticleNumber 19922
Author Saha, Sharmistha
Shom, Sayanti
Dutta, Nilanjana
Sinha, Swagata
Chatterjee, Mahasweta
Mukhopadhyay, Kanchan
Author_xml – sequence: 1
  givenname: Mahasweta
  surname: Chatterjee
  fullname: Chatterjee, Mahasweta
  organization: Manovikas Biomedical Research and Diagnostic Centre, Manovikas Kendra
– sequence: 2
  givenname: Sharmistha
  surname: Saha
  fullname: Saha, Sharmistha
  organization: Manovikas Biomedical Research and Diagnostic Centre, Manovikas Kendra
– sequence: 3
  givenname: Sayanti
  surname: Shom
  fullname: Shom, Sayanti
  organization: Manovikas Biomedical Research and Diagnostic Centre, Manovikas Kendra
– sequence: 4
  givenname: Nilanjana
  surname: Dutta
  fullname: Dutta, Nilanjana
  organization: Manovikas Biomedical Research and Diagnostic Centre, Manovikas Kendra
– sequence: 5
  givenname: Swagata
  surname: Sinha
  fullname: Sinha, Swagata
  organization: Manovikas Biomedical Research and Diagnostic Centre, Manovikas Kendra
– sequence: 6
  givenname: Kanchan
  surname: Mukhopadhyay
  fullname: Mukhopadhyay, Kanchan
  email: kanchanmvk@yahoo.com
  organization: Manovikas Biomedical Research and Diagnostic Centre, Manovikas Kendra
BookMark eNp9kc1u1TAUhCNUJErpC7CyxIZN6PFPYntZtdBeqRIbWFuOcxJyldjBdirxDjw05gYKYoE3to6_GXk8L6szHzxW1WsK7yhwdZUEbbSqgfFaSEpl3TyrzhmIpmacsbO_zi-qy5SOUFbDtKD6vPp-N2_ZLjYjiehwzSGSET3myZFHGyfrcyJ2GNBl7MmKcVq_YLQzGX_r4ljQHK1Py5TSFDyxvi8DtHlBn8nk-80V7bSsMTziaRYGcvB9MSfXt_e3pFx0RZReVc8HOye8_LVfVJ8_vP90c18_fLw73Fw_1E5Qnms3tJZDy1t0UpRYkjOqWtHYhvYSFTQ9DANTTrlOa6f6FhoABlR3vZUgBb-oDrtvH-zRrHFabPxmgp3MaRDiaGwsPzCjEdJS2XdadUoLKZ1qoGtRO4GgmRqG4vV29yohvm6Ysinf4HCercewJcOUBt5SCVDQN_-gx7BFX5IWSmkFUFIUiu2UiyGliMPTAymYn32bvW9T-janvk1TRHwXpQL7EeMf6_-ofgCv1bBf
Cites_doi 10.1002/ajmg.b.31246
10.3390/genes11121445
10.1016/j.rasd.2012.12.005
10.1037/t37378-000
10.1523/JNEUROSCI.1497-06.2006
10.1016/j.cpr.2015.05.005
10.1016/j.bbr.2012.01.046
10.1371/journal.pone.0032969
10.1016/S0301-0082(97)00085-3
10.4103/2229-516X.157162
10.1002/ajmg.b.32726
10.1038/s41598-022-21948-0
10.1146/annurev-neuro-071714-033821
10.1002/ajmg.b.30867
10.1016/S2215-0366(16)30032-3
10.1038/tp.2014.11
10.1016/j.schres.2008.01.027
10.4103/psychiatry.IndianJPsychiatry_543_18
10.1038/eye.2016.8
10.1177/0009922812446744
10.1007/s11920-014-0497-1
10.1016/j.jtbi.2005.11.036
10.1097/00002826-200307000-00013
10.1186/1744-9081-9-1
10.1177/0269881116667707
10.1038/tp.2016.273
10.1038/ng.1013
10.1038/npp.2015.153
10.1542/peds.2014-3482
10.1016/j.euroneuro.2015.06.003
10.1002/ajmg.b.30294
10.1177/1087054720905089
10.1023/B:MEBR.0000027415.75432.ad
10.1093/bioinformatics/bth457
10.1007/s40263-020-00702-y
10.1016/j.mgene.2016.11.007
10.1007/s40120-022-00392-2
10.1023/A:1022602400621
10.1038/s41380-018-0070-0
10.1016/S2215-0366(20)30312-6
10.1371/journal.pone.0051910
10.1515/dmpt-2022-0120
10.1007/s00213-014-3479-4
10.1038/mp.2012.126
10.1111/j.1460-9568.2010.07164.x
10.1007/s00787-018-1211-3
10.1007/s00787-014-0627-7
10.1042/BSR20181347
10.1007/s10519-010-9437-y
10.1093/nar/16.3.1215
10.1016/j.neuropharm.2012.06.005
10.1542/peds.2019-2528
10.1016/S0006-3223(02)01401-4
10.1016/j.alcohol.2015.10.005
10.1159/000119108
10.1016/S2215-0366(18)30269-4
10.1016/S0166-4328(02)00272-3
10.1089/cap.2013.0079
10.3389/fpsyt.2011.00065
10.1176/appi.books.9780890425596
10.1186/1756-0500-6-203
10.1016/S2215-0366(16)00096-1
10.1016/j.neulet.2021.136086
10.1176/appi.ajp.2011.11040551
ContentType Journal Article
Copyright The Author(s) 2023
The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2023. The Author(s).
Copyright_xml – notice: The Author(s) 2023
– notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2023. The Author(s).
DBID C6C
AAYXX
CITATION
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
DOA
DOI 10.1038/s41598-023-47117-5
DatabaseName Springer Nature OA Free Journals
CrossRef
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection (ProQuest)
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Medical Database
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
DOAJ Open Access Full Text
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
CrossRef

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
EndPage 14
ExternalDocumentID oai_doaj_org_article_47a17db98b89477c850b6e9c4e0928ff
10_1038_s41598_023_47117_5
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFPKN
CITATION
PHGZM
PHGZT
7XB
8FK
AARCD
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
Q9U
7X8
PUEGO
ID FETCH-LOGICAL-c413t-cf6a30636ec7423273218645a51d7e805d0ff28c8cb99c8d605002019bda70743
IEDL.DBID 7X7
ISSN 2045-2322
IngestDate Wed Aug 27 01:25:50 EDT 2025
Fri Jul 11 11:42:06 EDT 2025
Wed Aug 13 07:17:18 EDT 2025
Tue Jul 01 03:57:52 EDT 2025
Fri Feb 21 02:39:50 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c413t-cf6a30636ec7423273218645a51d7e805d0ff28c8cb99c8d605002019bda70743
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/2889800864?pq-origsite=%requestingapplication%
PQID 2889800864
PQPubID 2041939
PageCount 14
ParticipantIDs doaj_primary_oai_doaj_org_article_47a17db98b89477c850b6e9c4e0928ff
proquest_miscellaneous_2890361700
proquest_journals_2889800864
crossref_primary_10_1038_s41598_023_47117_5
springer_journals_10_1038_s41598_023_47117_5
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-11-14
PublicationDateYYYYMMDD 2023-11-14
PublicationDate_xml – month: 11
  year: 2023
  text: 2023-11-14
  day: 14
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationYear 2023
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References ElsayedNAYamamotoKMFroehlichTEGenetic influence on efficacy of pharmacotherapy for pediatric attention-deficit/hyperactivity disorder: Overview and current status of researchCNS Drugs.2020343894141:CAS:528:DC%2BB3cXksFequ7c%3D32133580808389510.1007/s40263-020-00702-y
ConnersCKParkerJDASitareniosGEpsteinJNThe Revised Conners’ Parent Rating Scale (CPRS-R): Factor structure, reliability, and criterion validityJ. Abnorm. Child. Psychol.1998262572681:STN:280:DyaK1czmsFyktw%3D%3D970051810.1023/A:1022602400621
HuangXWangMZhangQChenXWuJThe role of glutamate receptors in attention-deficit/hyperactivity disorder: From physiology to diseaseAm. J. Med. Genet. B20191802722861:CAS:528:DC%2BC1MXptFamtr8%3D10.1002/ajmg.b.32726
Lasky-SuJGenome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associationsAm. J. Med. Genet. B20081471345135410.1002/ajmg.b.30867
ChatterjeeMSahaSDuttaNSinhaSMukhopadhyayKKainate receptor subunit 1 (GRIK1) risk variants and GRIK1 deficiency were detected in the Indian ADHD probandsSci. Rep.202212184492022NatSR..1218449C1:CAS:528:DC%2BB38XivVWitbzJ36323684963044710.1038/s41598-022-21948-0
VolkLChiuSLSharmaKHuganirRLGlutamate synapses in human cognitive disordersAnnu. Rev. Neurosci.2015381271491:CAS:528:DC%2BC2MXhsVCjurfE2589787310.1146/annurev-neuro-071714-033821
EliaJGenome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorderNat. Genet.20124478841:CAS:528:DC%2BC3MXhsFGktbvL10.1038/ng.1013
WolraichMLClinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescentsPediatrics20191443157064810.1542/peds.2019-2528
StergiakouliEInvestigating the contribution of common genetic variants to the risk and pathogenesis of ADHDAm. J. Psychiatry201216918619422420046360140410.1176/appi.ajp.2011.11040551
MaltezosSGlutamate/glutamine and neuronal integrity in adults with ADHD: a proton MRS studyTransl. Psychiatry.201441:CAS:528:DC%2BC2cXjsVGhsbg%3D24643164396603910.1038/tp.2014.11
Callaerts-VeghZConcomitant deficits in working memory and fear extinction are functionally dissociated from reduced anxiety in metabotropic glutamate receptor 7-deficient miceJ. Neurosci.200626657365821:CAS:528:DC%2BD28Xmt1ersL0%3D16775145667405010.1523/JNEUROSCI.1497-06.2006
FaraoneSVLarssonHGenetics of attention deficit hyperactivity disorderMol. Psychiatry2019245625751:CAS:528:DC%2BC1cXht1CjsLvP2989205410.1038/s41380-018-0070-0
KamHJeongHPharmacogenomic biomarkers and their applications in PsychiatryGenes.20201114451:CAS:528:DC%2BB3MXhtFWmu7s%3D33266292776081810.3390/genes11121445
ChenWTaylorEParental account of children's symptoms (PACS), ADHD phenotypes and its application to molecular genetic studiesAm. Psychol. Assoc.20061320
CorteseSComparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysisLancet Psychiatry.2018572773830097390610910710.1016/S2215-0366(18)30269-4
BurtonCLFletcherPJAge and sex differences in impulsive action in rats: The role of dopamine and glutamateBehav. Brain. Res.201223021331:CAS:528:DC%2BC38Xktleqt74%3D2232637210.1016/j.bbr.2012.01.046
OhtsukiTA polymorphism of the metabotropic glutamate receptor mGluR7 (GRM7) gene is associated with schizophreniaSchizophr. Res.20081019161832924810.1016/j.schres.2008.01.027
American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders20004American Psychiatric Association
LehohlaMKellawayLRussellVANMDA receptor function in the prefrontal cortex of a rat model for attention-deficit hyperactivity disorderMetab. Brain. Dis.20041935421:CAS:528:DC%2BD2cXjvVKnt7Y%3D1521450410.1023/B:MEBR.0000027415.75432.ad
QuinteroJGutiérrez-CasaresJRÁlamoCMolecular characterisation of the mechanism of action of stimulant drugs lisdexamfetamine and methylphenidate on ADHD neurobiology: A ReviewNeurol. Ther.2022111489151735951288958813610.1007/s40120-022-00392-2
FuruseTPhenotypic characterization of a new Grin1 mutant mouse generated by ENU mutagenesisEur. J. Neurosci.201031128112912034591510.1111/j.1460-9568.2010.07164.x
EndeGImpulsivity and aggression in female BPD and ADHD patients: Association with ACC glutamate and GABA concentrationsNeuropsychopharmacology2016414104181:CAS:528:DC%2BC2MXitVWrtbbP2604050310.1038/npp.2015.153
ParkSThe metabotropic glutamate receptor subtype 7 rs3792452 polymorphism is associated with the response to methylphenidate in children with attention-deficit/hyperactivity disorderJ. Child. Adolesc. Psychopharmacol.2014242232271:CAS:528:DC%2BC2cXotFGit7c%3D2481573110.1089/cap.2013.0079
SkafidasEPredicting the diagnosis of autism spectrum disorder using gene pathway analysisMol. Psychiatry.2014195045101:CAS:528:DC%2BC2cXkvVKju7Y%3D2296500610.1038/mp.2012.126
MowlemFDSex differences in predicting ADHD clinical diagnosis and pharmacological treatmentEur. Child Adolesc. Psychiatry.2019284814893009772310.1007/s00787-018-1211-3
RivaVGRIN2B predicts attention problems among disadvantaged childrenEur. Child Adolesc. Psychiatry.2015248278362531609510.1007/s00787-014-0627-7
DudbridgeFLikelihood-based association analysis for nuclear families and unrelated subjects with missing genotype dataHum. Hered.20086687981838208810.1159/000119108
ThomasRSandersSDoustJBellerEGlasziouPPrevalence of attention-deficit/hyperactivity disorder: A systematic review and meta-analysisPediatrics2015135e994e10012573375410.1542/peds.2014-3482
YadavRDeletion of Glutamate Delta-1 receptor in mouse leads to aberrant emotional and social behaviorsPLoS ONE201272012PLoSO...732969Y1:CAS:528:DC%2BC38XktF2gsbk%3D22412961329675910.1371/journal.pone.0032969
OzawaSKamiyaHTsuzukiKGlutamate receptors in the mammalian central nervous systemProg. Neurobiol.1998545816181:CAS:528:DyaK1cXitlymt7w%3D955019210.1016/S0301-0082(97)00085-3
RayADimorphic association of dopaminergic transporter gene variants with treatment outcome: Pilot study in Indian ADHD probandsMeta Gene.201711646910.1016/j.mgene.2016.11.007
ToomeySLSoxCMRusinakDFinkelsteinJAWhy do children with ADHD discontinue their medication?Clin. Pediatr.20125176376910.1177/0009922812446744
MillerEMPomerleauFHuettlPGerhardtGAGlaserPEAberrant glutamate signaling in the prefrontal cortex and striatum of the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorderPsychopharmacology2014231301930291:CAS:528:DC%2BC2cXjt12it7s%3D2468250010.1007/s00213-014-3479-4
ParkSAssociation between the GRM7 rs3792452 polymorphism and attention deficit hyperactivity disorder in a Korean sampleBehav. Brain Funct.2013912013daao.book.....P1:CAS:528:DC%2BC3sXhtVGju7rK23295062368005310.1186/1744-9081-9-1
MillerSADykesDDPoleskyHFA simple salting out procedure for extracting DNA from human nucleated cellsNucleic. Acids. Res.19881612151:CAS:528:DyaL1cXhsVKlsrs%3D334421633476510.1093/nar/16.3.1215
UmemoriJENU-mutagenesis mice with a non-synonymous mutation in Grin1 exhibit abnormal anxiety-like behaviors, impaired fear memory, and decreased acoustic startle responseBMC Res. Notes201362032031:CAS:528:DC%2BC3sXhtVSktbvK23688147367494110.1186/1756-0500-6-203
ShahRGroverSAvasthiAClinical practice guidelines for the assessment and management of Attention-Deficit/Hyperactivity DisorderIndian J. Psychiatry.20196117619330745695634513810.4103/psychiatry.IndianJPsychiatry_543_18
American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders20135American Psychiatric Association10.1176/appi.books.9780890425596
FaraoneSVBonviciniCScassellatiCBiomarkers in the diagnosis of ADHD- Promising directionsCurr. Psychiatry Rep.2014164972529812610.1007/s11920-014-0497-1
HinneyAGenome-wide association study in German patients with attention deficit/hyperactivity disorderAm. J. Med. Genet. B201115688889710.1002/ajmg.b.31246
MagriCGlutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia: A pilot case-control association study in an Italian sampleAm. J. Med. Genet. B.200614128729310.1002/ajmg.b.30294
MooreJHA flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibilityJ. Theor. Biol.20062412522612006JThBi.241..252M2254460164578521447.9225810.1016/j.jtbi.2005.11.036
MukherjeeSManahan-VaughanDRole of metabotropic glutamate receptors in persistent forms of hippocampal plasticity and learningNeuropharmacology.20136665811:CAS:528:DC%2BC38XhtlCju7vF2274315910.1016/j.neuropharm.2012.06.005
KimJHEnvironmental risk factors, protective factors, and peripheral biomarkers for ADHD: an umbrella reviewLancet. Psychiatry.202079559703306931810.1016/S2215-0366(20)30312-6
GargJArunPChavanBSComparative efficacy of methylphenidate and atomoxetine in oppositional defiant disorder comorbid with attention deficit hyperactivity disorderInt. J. Appl. Basic Med. Res.201551141181:CAS:528:DC%2BC2MXitVektrzN26097819445688510.4103/2229-516X.157162
BarrettJCFryBMallerJDalyMJHaploview: Analysis and visualization of LD and haplotype mapsBioinformatics2005212632651:CAS:528:DC%2BD2MXkt1WitQ%3D%3D1529730010.1093/bioinformatics/bth457
AshersonPBuitelaarJFaraoneSVRohdeLAAdult attention-deficit hyperactivity disorder: Key conceptual issuesLancet Psychiatry201635685782718390110.1016/S2215-0366(16)30032-3
MacMasterFPCarreyNSparkesSKusumakarVProton spectroscopy in medication-free pediatric attention-deficit/hyperactivity disorderBiol. Psychiatry.2003531841871254747610.1016/S0006-3223(02)01401-4
GaoXWangJQuantitative assessment of the association between GRIA1 polymorphisms and migraine riskBiosci. Rep.201838BSR2018134730446525629462110.1042/BSR20181347
GalloEFPosnerJMoving towards causality in attention-deficit hyperactivity disorder: Overview of neural and genetic mechanismsLancet Psychiatry.2016355556727183902489388010.1016/S2215-0366(16)00096-1
Melr
J Garg (47117_CR51) 2015; 5
F Dudbridge (47117_CR67) 2008; 66
S Mukherjee (47117_CR33) 2013; 66
R Thomas (47117_CR2) 2015; 135
JI Kim (47117_CR39) 2017; 31
W Chen (47117_CR65) 2006; 1
P Asherson (47117_CR4) 2016; 3
NA Elsayed (47117_CR15) 2020; 34
N Carrey (47117_CR41) 2003; 26
A Hinney (47117_CR28) 2011; 156
L Volk (47117_CR34) 2015; 38
R Shah (47117_CR52) 2019; 61
G Riedel (47117_CR26) 2003; 140
J Elia (47117_CR42) 2012; 44
TH Hassan (47117_CR32) 2013; 7
X Gao (47117_CR49) 2018; 38
T Tan-Kam (47117_CR57) 2013; 6
JH Kim (47117_CR27) 2020; 7
A Ray (47117_CR50) 2017; 11
LC Bidwell (47117_CR10) 2011; 41
J Quintero (47117_CR53) 2022; 11
R Yadav (47117_CR24) 2012; 7
E Stergiakouli (47117_CR30) 2012; 169
JC Barrett (47117_CR69) 2005; 21
J Buitelaar (47117_CR58) 2015; 25
JH Moore (47117_CR70) 2006; 241
S Park (47117_CR35) 2013; 9
Z Callaerts-Vegh (47117_CR45) 2006; 26
WE Melroy-Greif (47117_CR46) 2016; 55
SL Toomey (47117_CR56) 2012; 51
SV Faraone (47117_CR11) 2014; 16
D Williamson (47117_CR6) 2015; 40
S Cortese (47117_CR9) 2018; 5
V Riva (47117_CR36) 2015; 24
Y Wang (47117_CR12) 2021; 760
American Psychiatric Association (47117_CR61) 2000
X Huang (47117_CR13) 2019; 180
S Park (47117_CR40) 2014; 24
H Wang (47117_CR44) 2016; 30
G Ende (47117_CR18) 2016; 41
M Dramsdahl (47117_CR38) 2011; 2
SV Faraone (47117_CR7) 2019; 24
T Furuse (47117_CR21) 2010; 31
M Lehohla (47117_CR22) 2004; 19
C Magri (47117_CR48) 2006; 141
M Chatterjee (47117_CR59) 2022; 38
FP MacMaster (47117_CR17) 2003; 53
CK Conners (47117_CR62) 1998; 26
EF Gallo (47117_CR8) 2016; 3
47117_CR68
Q Zhang (47117_CR14) 2021; 25
SA Miller (47117_CR66) 1988; 16
ML Wolraich (47117_CR3) 2019; 144
EM Miller (47117_CR20) 2014; 231
J Lasky-Su (47117_CR29) 2008; 147
T Ohtsuki (47117_CR47) 2008; 101
47117_CR64
S Maltezos (47117_CR37) 2014; 4
J Elia (47117_CR54) 2020; 1
American Psychiatric Association (47117_CR1) 2013
M Chatterjee (47117_CR31) 2022; 12
E Skafidas (47117_CR43) 2014; 19
CL Zhang (47117_CR55) 2012; 7
CL Burton (47117_CR19) 2012; 230
S Ozawa (47117_CR25) 1998; 54
H Kam (47117_CR60) 2020; 11
J Umemori (47117_CR23) 2013; 6
J Naaijen (47117_CR16) 2017; 10
FD Mowlem (47117_CR5) 2019; 28
D Wechsler (47117_CR63) 1991
References_xml – reference: HinneyAGenome-wide association study in German patients with attention deficit/hyperactivity disorderAm. J. Med. Genet. B201115688889710.1002/ajmg.b.31246
– reference: MaltezosSGlutamate/glutamine and neuronal integrity in adults with ADHD: a proton MRS studyTransl. Psychiatry.201441:CAS:528:DC%2BC2cXjsVGhsbg%3D24643164396603910.1038/tp.2014.11
– reference: MillerEMPomerleauFHuettlPGerhardtGAGlaserPEAberrant glutamate signaling in the prefrontal cortex and striatum of the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorderPsychopharmacology2014231301930291:CAS:528:DC%2BC2cXjt12it7s%3D2468250010.1007/s00213-014-3479-4
– reference: GaoXWangJQuantitative assessment of the association between GRIA1 polymorphisms and migraine riskBiosci. Rep.201838BSR2018134730446525629462110.1042/BSR20181347
– reference: ElsayedNAYamamotoKMFroehlichTEGenetic influence on efficacy of pharmacotherapy for pediatric attention-deficit/hyperactivity disorder: Overview and current status of researchCNS Drugs.2020343894141:CAS:528:DC%2BB3cXksFequ7c%3D32133580808389510.1007/s40263-020-00702-y
– reference: LehohlaMKellawayLRussellVANMDA receptor function in the prefrontal cortex of a rat model for attention-deficit hyperactivity disorderMetab. Brain. Dis.20041935421:CAS:528:DC%2BD2cXjvVKnt7Y%3D1521450410.1023/B:MEBR.0000027415.75432.ad
– reference: FaraoneSVBonviciniCScassellatiCBiomarkers in the diagnosis of ADHD- Promising directionsCurr. Psychiatry Rep.2014164972529812610.1007/s11920-014-0497-1
– reference: VolkLChiuSLSharmaKHuganirRLGlutamate synapses in human cognitive disordersAnnu. Rev. Neurosci.2015381271491:CAS:528:DC%2BC2MXhsVCjurfE2589787310.1146/annurev-neuro-071714-033821
– reference: KimJHEnvironmental risk factors, protective factors, and peripheral biomarkers for ADHD: an umbrella reviewLancet. Psychiatry.202079559703306931810.1016/S2215-0366(20)30312-6
– reference: ConnersCKParkerJDASitareniosGEpsteinJNThe Revised Conners’ Parent Rating Scale (CPRS-R): Factor structure, reliability, and criterion validityJ. Abnorm. Child. Psychol.1998262572681:STN:280:DyaK1czmsFyktw%3D%3D970051810.1023/A:1022602400621
– reference: ChatterjeeMSahaSDuttaNSinhaSMukhopadhyayKKainate receptor subunit 1 (GRIK1) risk variants and GRIK1 deficiency were detected in the Indian ADHD probandsSci. Rep.202212184492022NatSR..1218449C1:CAS:528:DC%2BB38XivVWitbzJ36323684963044710.1038/s41598-022-21948-0
– reference: KimJIAssociation of the GRIN2B rs2284411 polymorphism with methylphenidate response in attention-deficit/hyperactivity disorderJ. Psychopharmacol.201731107010771:CAS:528:DC%2BC1cXitVyiurw%3D2762415010.1177/0269881116667707
– reference: RiedelGPlattBMicheauJGlutamate receptor function in learning and memoryBehav. Brain. Res.20031401471:CAS:528:DC%2BD3sXitV2ht70%3D1264427610.1016/S0166-4328(02)00272-3
– reference: ParkSThe metabotropic glutamate receptor subtype 7 rs3792452 polymorphism is associated with the response to methylphenidate in children with attention-deficit/hyperactivity disorderJ. Child. Adolesc. Psychopharmacol.2014242232271:CAS:528:DC%2BC2cXotFGit7c%3D2481573110.1089/cap.2013.0079
– reference: OhtsukiTA polymorphism of the metabotropic glutamate receptor mGluR7 (GRM7) gene is associated with schizophreniaSchizophr. Res.20081019161832924810.1016/j.schres.2008.01.027
– reference: GargJArunPChavanBSComparative efficacy of methylphenidate and atomoxetine in oppositional defiant disorder comorbid with attention deficit hyperactivity disorderInt. J. Appl. Basic Med. Res.201551141181:CAS:528:DC%2BC2MXitVektrzN26097819445688510.4103/2229-516X.157162
– reference: American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders20135American Psychiatric Association10.1176/appi.books.9780890425596
– reference: DudbridgeFLikelihood-based association analysis for nuclear families and unrelated subjects with missing genotype dataHum. Hered.20086687981838208810.1159/000119108
– reference: ShahRGroverSAvasthiAClinical practice guidelines for the assessment and management of Attention-Deficit/Hyperactivity DisorderIndian J. Psychiatry.20196117619330745695634513810.4103/psychiatry.IndianJPsychiatry_543_18
– reference: ToomeySLSoxCMRusinakDFinkelsteinJAWhy do children with ADHD discontinue their medication?Clin. Pediatr.20125176376910.1177/0009922812446744
– reference: Barkley, R. A. Barkley Deficits in Executive Functioning Scale—Children and Adolescents (BDEFS-CA) (The Guilford Press, 2012).
– reference: QuinteroJGutiérrez-CasaresJRÁlamoCMolecular characterisation of the mechanism of action of stimulant drugs lisdexamfetamine and methylphenidate on ADHD neurobiology: A ReviewNeurol. Ther.2022111489151735951288958813610.1007/s40120-022-00392-2
– reference: American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders20004American Psychiatric Association
– reference: Callaerts-VeghZConcomitant deficits in working memory and fear extinction are functionally dissociated from reduced anxiety in metabotropic glutamate receptor 7-deficient miceJ. Neurosci.200626657365821:CAS:528:DC%2BD28Xmt1ersL0%3D16775145667405010.1523/JNEUROSCI.1497-06.2006
– reference: WangYPolygenic risk of genes involved in the catecholamine and serotonin pathways for ADHD in childrenNeurosci. Lett.20217601:CAS:528:DC%2BB3MXhsVansL7I3417434410.1016/j.neulet.2021.136086
– reference: ZhangCLMethylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: A novel mechanism for methylphenidate actionPLoS ONE201272012PLoSO...751910Z1:CAS:528:DC%2BC3sXlsVGitw%3D%3D23284812352739610.1371/journal.pone.0051910
– reference: HuangXWangMZhangQChenXWuJThe role of glutamate receptors in attention-deficit/hyperactivity disorder: From physiology to diseaseAm. J. Med. Genet. B20191802722861:CAS:528:DC%2BC1MXptFamtr8%3D10.1002/ajmg.b.32726
– reference: CorteseSComparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysisLancet Psychiatry.2018572773830097390610910710.1016/S2215-0366(18)30269-4
– reference: EndeGImpulsivity and aggression in female BPD and ADHD patients: Association with ACC glutamate and GABA concentrationsNeuropsychopharmacology2016414104181:CAS:528:DC%2BC2MXitVWrtbbP2604050310.1038/npp.2015.153
– reference: StergiakouliEInvestigating the contribution of common genetic variants to the risk and pathogenesis of ADHDAm. J. Psychiatry201216918619422420046360140410.1176/appi.ajp.2011.11040551
– reference: MagriCGlutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia: A pilot case-control association study in an Italian sampleAm. J. Med. Genet. B.200614128729310.1002/ajmg.b.30294
– reference: MowlemFDSex differences in predicting ADHD clinical diagnosis and pharmacological treatmentEur. Child Adolesc. Psychiatry.2019284814893009772310.1007/s00787-018-1211-3
– reference: Tan-KamTImportance of pharmacogenetics in the treatment of children with attention deficit hyperactive disorder: A case reportPharmacogenom. Pers. Med.2013637
– reference: EliaJIzakiYAmbrosiniAHakonarsonHGlutamatergic neurotransmission in ADHD: Neurodevelopment and pharmacological implicationsPediatr. Neonatol.202011006
– reference: Lasky-SuJGenome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associationsAm. J. Med. Genet. B20081471345135410.1002/ajmg.b.30867
– reference: DramsdahlMAdults with attention-deficit/hyperactivity disorder - A brain magnetic resonance spectroscopy studyFront. Psychiatry.20112651:CAS:528:DC%2BC38Xis1Squw%3D%3D22131979322288410.3389/fpsyt.2011.00065
– reference: ZhangQAssociation of gene variations in ionotropic glutamate receptor and attention-deficit/hyperactivity disorder in the Chinese population: A two-stage case-control studyJ Atten. Disord.202125136213733206500210.1177/1087054720905089
– reference: FaraoneSVLarssonHGenetics of attention deficit hyperactivity disorderMol. Psychiatry2019245625751:CAS:528:DC%2BC1cXht1CjsLvP2989205410.1038/s41380-018-0070-0
– reference: GalloEFPosnerJMoving towards causality in attention-deficit hyperactivity disorder: Overview of neural and genetic mechanismsLancet Psychiatry.2016355556727183902489388010.1016/S2215-0366(16)00096-1
– reference: BurtonCLFletcherPJAge and sex differences in impulsive action in rats: The role of dopamine and glutamateBehav. Brain. Res.201223021331:CAS:528:DC%2BC38Xktleqt74%3D2232637210.1016/j.bbr.2012.01.046
– reference: KamHJeongHPharmacogenomic biomarkers and their applications in PsychiatryGenes.20201114451:CAS:528:DC%2BB3MXhtFWmu7s%3D33266292776081810.3390/genes11121445
– reference: ParkSAssociation between the GRM7 rs3792452 polymorphism and attention deficit hyperactivity disorder in a Korean sampleBehav. Brain Funct.2013912013daao.book.....P1:CAS:528:DC%2BC3sXhtVGju7rK23295062368005310.1186/1744-9081-9-1
– reference: BarrettJCFryBMallerJDalyMJHaploview: Analysis and visualization of LD and haplotype mapsBioinformatics2005212632651:CAS:528:DC%2BD2MXkt1WitQ%3D%3D1529730010.1093/bioinformatics/bth457
– reference: CarreyNMetabolite changes resulting from treatment in children with ADHD: a 1H-MRS studyClin. Neuropharmacol.2003262182211289764410.1097/00002826-200307000-00013
– reference: SkafidasEPredicting the diagnosis of autism spectrum disorder using gene pathway analysisMol. Psychiatry.2014195045101:CAS:528:DC%2BC2cXkvVKju7Y%3D2296500610.1038/mp.2012.126
– reference: OzawaSKamiyaHTsuzukiKGlutamate receptors in the mammalian central nervous systemProg. Neurobiol.1998545816181:CAS:528:DyaK1cXitlymt7w%3D955019210.1016/S0301-0082(97)00085-3
– reference: BuitelaarJDifferences in maintenance of response upon discontinuation across medication treatments in attention-deficit/hyperactivity disorderEur. Neuropsychopharmacol.201525161116211:CAS:528:DC%2BC2MXhtV2ls7jK2616957410.1016/j.euroneuro.2015.06.003
– reference: BidwellLCA family-based association study of DRD4, DAT1, and 5HTT and continuous traits of attention-deficit hyperactivity disorderBehav. Genet.20114116517421207241367402210.1007/s10519-010-9437-y
– reference: Lenth, R. V. Java Applets for Power and Sample Size [Computer Software] (2006).
– reference: HassanTHBlood and brain glutamate levels in children with autistic disorderRes. Autism Spectr. Disord.2013754154810.1016/j.rasd.2012.12.005
– reference: AshersonPBuitelaarJFaraoneSVRohdeLAAdult attention-deficit hyperactivity disorder: Key conceptual issuesLancet Psychiatry201635685782718390110.1016/S2215-0366(16)30032-3
– reference: WechslerDWechsler Intelligence Scale for Children19913Psychological Corporation
– reference: ChatterjeeMPost-treatment symptomatic improvement of the eastern Indian ADHD probands is influenced by CYP2D6 genetic variationsDrug. Metab. Pers. Ther.20223845563616923510.1515/dmpt-2022-0120
– reference: YadavRDeletion of Glutamate Delta-1 receptor in mouse leads to aberrant emotional and social behaviorsPLoS ONE201272012PLoSO...732969Y1:CAS:528:DC%2BC38XktF2gsbk%3D22412961329675910.1371/journal.pone.0032969
– reference: NaaijenJGlutamatergic and GABAergic gene sets in attention-deficit/hyperactivity disorder: Association to overlapping traits in ADHD and autismTransl Psychiatry.20171010.1038/tp.2016.273
– reference: MukherjeeSManahan-VaughanDRole of metabotropic glutamate receptors in persistent forms of hippocampal plasticity and learningNeuropharmacology.20136665811:CAS:528:DC%2BC38XhtlCju7vF2274315910.1016/j.neuropharm.2012.06.005
– reference: UmemoriJENU-mutagenesis mice with a non-synonymous mutation in Grin1 exhibit abnormal anxiety-like behaviors, impaired fear memory, and decreased acoustic startle responseBMC Res. Notes201362032031:CAS:528:DC%2BC3sXhtVSktbvK23688147367494110.1186/1756-0500-6-203
– reference: ChenWTaylorEParental account of children's symptoms (PACS), ADHD phenotypes and its application to molecular genetic studiesAm. Psychol. Assoc.20061320
– reference: MacMasterFPCarreyNSparkesSKusumakarVProton spectroscopy in medication-free pediatric attention-deficit/hyperactivity disorderBiol. Psychiatry.2003531841871254747610.1016/S0006-3223(02)01401-4
– reference: WangHAssociation of ZNF644, GRM6, and CTNND2 genes with high myopia in the Han Chinese population: Jiangsu Eye StudyEye201630101710221:CAS:528:DC%2BC28XlvVahsLY%3D27034204494107910.1038/eye.2016.8
– reference: WilliamsonDJohnstonCGender differences in adults with attention-deficit/hyperactivity disorder: A narrative reviewClin. Psychol. Rev.20154015272604662410.1016/j.cpr.2015.05.005
– reference: RivaVGRIN2B predicts attention problems among disadvantaged childrenEur. Child Adolesc. Psychiatry.2015248278362531609510.1007/s00787-014-0627-7
– reference: MooreJHA flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibilityJ. Theor. Biol.20062412522612006JThBi.241..252M2254460164578521447.9225810.1016/j.jtbi.2005.11.036
– reference: FuruseTPhenotypic characterization of a new Grin1 mutant mouse generated by ENU mutagenesisEur. J. Neurosci.201031128112912034591510.1111/j.1460-9568.2010.07164.x
– reference: MillerSADykesDDPoleskyHFA simple salting out procedure for extracting DNA from human nucleated cellsNucleic. Acids. Res.19881612151:CAS:528:DyaL1cXhsVKlsrs%3D334421633476510.1093/nar/16.3.1215
– reference: EliaJGenome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorderNat. Genet.20124478841:CAS:528:DC%2BC3MXhsFGktbvL10.1038/ng.1013
– reference: WolraichMLClinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescentsPediatrics20191443157064810.1542/peds.2019-2528
– reference: Melroy-GreifWETest for association of common variants in GRM7 with alcohol consumptionAlcohol.20165543501:CAS:528:DC%2BC28Xhs1SmurfE27788777512369810.1016/j.alcohol.2015.10.005
– reference: RayADimorphic association of dopaminergic transporter gene variants with treatment outcome: Pilot study in Indian ADHD probandsMeta Gene.201711646910.1016/j.mgene.2016.11.007
– reference: ThomasRSandersSDoustJBellerEGlasziouPPrevalence of attention-deficit/hyperactivity disorder: A systematic review and meta-analysisPediatrics2015135e994e10012573375410.1542/peds.2014-3482
– volume: 156
  start-page: 888
  year: 2011
  ident: 47117_CR28
  publication-title: Am. J. Med. Genet. B
  doi: 10.1002/ajmg.b.31246
– volume: 11
  start-page: 1445
  year: 2020
  ident: 47117_CR60
  publication-title: Genes.
  doi: 10.3390/genes11121445
– volume: 7
  start-page: 541
  year: 2013
  ident: 47117_CR32
  publication-title: Res. Autism Spectr. Disord.
  doi: 10.1016/j.rasd.2012.12.005
– ident: 47117_CR64
  doi: 10.1037/t37378-000
– volume: 26
  start-page: 6573
  year: 2006
  ident: 47117_CR45
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.1497-06.2006
– volume: 40
  start-page: 15
  year: 2015
  ident: 47117_CR6
  publication-title: Clin. Psychol. Rev.
  doi: 10.1016/j.cpr.2015.05.005
– volume: 230
  start-page: 21
  year: 2012
  ident: 47117_CR19
  publication-title: Behav. Brain. Res.
  doi: 10.1016/j.bbr.2012.01.046
– volume: 7
  year: 2012
  ident: 47117_CR24
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0032969
– volume: 54
  start-page: 581
  year: 1998
  ident: 47117_CR25
  publication-title: Prog. Neurobiol.
  doi: 10.1016/S0301-0082(97)00085-3
– volume: 5
  start-page: 114
  year: 2015
  ident: 47117_CR51
  publication-title: Int. J. Appl. Basic Med. Res.
  doi: 10.4103/2229-516X.157162
– volume: 180
  start-page: 272
  year: 2019
  ident: 47117_CR13
  publication-title: Am. J. Med. Genet. B
  doi: 10.1002/ajmg.b.32726
– volume: 12
  start-page: 18449
  year: 2022
  ident: 47117_CR31
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-022-21948-0
– volume: 38
  start-page: 127
  year: 2015
  ident: 47117_CR34
  publication-title: Annu. Rev. Neurosci.
  doi: 10.1146/annurev-neuro-071714-033821
– volume: 147
  start-page: 1345
  year: 2008
  ident: 47117_CR29
  publication-title: Am. J. Med. Genet. B
  doi: 10.1002/ajmg.b.30867
– volume: 3
  start-page: 568
  year: 2016
  ident: 47117_CR4
  publication-title: Lancet Psychiatry
  doi: 10.1016/S2215-0366(16)30032-3
– volume: 4
  year: 2014
  ident: 47117_CR37
  publication-title: Transl. Psychiatry.
  doi: 10.1038/tp.2014.11
– volume: 101
  start-page: 9
  year: 2008
  ident: 47117_CR47
  publication-title: Schizophr. Res.
  doi: 10.1016/j.schres.2008.01.027
– volume: 61
  start-page: 176
  year: 2019
  ident: 47117_CR52
  publication-title: Indian J. Psychiatry.
  doi: 10.4103/psychiatry.IndianJPsychiatry_543_18
– volume: 30
  start-page: 1017
  year: 2016
  ident: 47117_CR44
  publication-title: Eye
  doi: 10.1038/eye.2016.8
– volume: 51
  start-page: 763
  year: 2012
  ident: 47117_CR56
  publication-title: Clin. Pediatr.
  doi: 10.1177/0009922812446744
– volume-title: Diagnostic and Statistical Manual of Mental Disorders
  year: 2000
  ident: 47117_CR61
– volume: 16
  start-page: 497
  year: 2014
  ident: 47117_CR11
  publication-title: Curr. Psychiatry Rep.
  doi: 10.1007/s11920-014-0497-1
– volume: 241
  start-page: 252
  year: 2006
  ident: 47117_CR70
  publication-title: J. Theor. Biol.
  doi: 10.1016/j.jtbi.2005.11.036
– volume: 26
  start-page: 218
  year: 2003
  ident: 47117_CR41
  publication-title: Clin. Neuropharmacol.
  doi: 10.1097/00002826-200307000-00013
– volume-title: Wechsler Intelligence Scale for Children
  year: 1991
  ident: 47117_CR63
– ident: 47117_CR68
– volume: 9
  start-page: 1
  year: 2013
  ident: 47117_CR35
  publication-title: Behav. Brain Funct.
  doi: 10.1186/1744-9081-9-1
– volume: 31
  start-page: 1070
  year: 2017
  ident: 47117_CR39
  publication-title: J. Psychopharmacol.
  doi: 10.1177/0269881116667707
– volume: 10
  year: 2017
  ident: 47117_CR16
  publication-title: Transl Psychiatry.
  doi: 10.1038/tp.2016.273
– volume: 44
  start-page: 78
  year: 2012
  ident: 47117_CR42
  publication-title: Nat. Genet.
  doi: 10.1038/ng.1013
– volume: 41
  start-page: 410
  year: 2016
  ident: 47117_CR18
  publication-title: Neuropsychopharmacology
  doi: 10.1038/npp.2015.153
– volume: 135
  start-page: e994
  year: 2015
  ident: 47117_CR2
  publication-title: Pediatrics
  doi: 10.1542/peds.2014-3482
– volume: 1
  start-page: 1006
  year: 2020
  ident: 47117_CR54
  publication-title: Pediatr. Neonatol.
– volume: 25
  start-page: 1611
  year: 2015
  ident: 47117_CR58
  publication-title: Eur. Neuropsychopharmacol.
  doi: 10.1016/j.euroneuro.2015.06.003
– volume: 141
  start-page: 287
  year: 2006
  ident: 47117_CR48
  publication-title: Am. J. Med. Genet. B.
  doi: 10.1002/ajmg.b.30294
– volume: 25
  start-page: 1362
  year: 2021
  ident: 47117_CR14
  publication-title: J Atten. Disord.
  doi: 10.1177/1087054720905089
– volume: 19
  start-page: 35
  year: 2004
  ident: 47117_CR22
  publication-title: Metab. Brain. Dis.
  doi: 10.1023/B:MEBR.0000027415.75432.ad
– volume: 21
  start-page: 263
  year: 2005
  ident: 47117_CR69
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bth457
– volume: 34
  start-page: 389
  year: 2020
  ident: 47117_CR15
  publication-title: CNS Drugs.
  doi: 10.1007/s40263-020-00702-y
– volume: 6
  start-page: 3
  year: 2013
  ident: 47117_CR57
  publication-title: Pharmacogenom. Pers. Med.
– volume: 11
  start-page: 64
  year: 2017
  ident: 47117_CR50
  publication-title: Meta Gene.
  doi: 10.1016/j.mgene.2016.11.007
– volume: 11
  start-page: 1489
  year: 2022
  ident: 47117_CR53
  publication-title: Neurol. Ther.
  doi: 10.1007/s40120-022-00392-2
– volume: 26
  start-page: 257
  year: 1998
  ident: 47117_CR62
  publication-title: J. Abnorm. Child. Psychol.
  doi: 10.1023/A:1022602400621
– volume: 1
  start-page: 3
  year: 2006
  ident: 47117_CR65
  publication-title: Am. Psychol. Assoc.
– volume: 24
  start-page: 562
  year: 2019
  ident: 47117_CR7
  publication-title: Mol. Psychiatry
  doi: 10.1038/s41380-018-0070-0
– volume: 7
  start-page: 955
  year: 2020
  ident: 47117_CR27
  publication-title: Lancet. Psychiatry.
  doi: 10.1016/S2215-0366(20)30312-6
– volume: 7
  year: 2012
  ident: 47117_CR55
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0051910
– volume: 38
  start-page: 45
  year: 2022
  ident: 47117_CR59
  publication-title: Drug. Metab. Pers. Ther.
  doi: 10.1515/dmpt-2022-0120
– volume: 231
  start-page: 3019
  year: 2014
  ident: 47117_CR20
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-014-3479-4
– volume: 19
  start-page: 504
  year: 2014
  ident: 47117_CR43
  publication-title: Mol. Psychiatry.
  doi: 10.1038/mp.2012.126
– volume: 31
  start-page: 1281
  year: 2010
  ident: 47117_CR21
  publication-title: Eur. J. Neurosci.
  doi: 10.1111/j.1460-9568.2010.07164.x
– volume: 28
  start-page: 481
  year: 2019
  ident: 47117_CR5
  publication-title: Eur. Child Adolesc. Psychiatry.
  doi: 10.1007/s00787-018-1211-3
– volume: 24
  start-page: 827
  year: 2015
  ident: 47117_CR36
  publication-title: Eur. Child Adolesc. Psychiatry.
  doi: 10.1007/s00787-014-0627-7
– volume: 38
  start-page: BSR20181347
  year: 2018
  ident: 47117_CR49
  publication-title: Biosci. Rep.
  doi: 10.1042/BSR20181347
– volume: 41
  start-page: 165
  year: 2011
  ident: 47117_CR10
  publication-title: Behav. Genet.
  doi: 10.1007/s10519-010-9437-y
– volume: 16
  start-page: 1215
  year: 1988
  ident: 47117_CR66
  publication-title: Nucleic. Acids. Res.
  doi: 10.1093/nar/16.3.1215
– volume: 66
  start-page: 65
  year: 2013
  ident: 47117_CR33
  publication-title: Neuropharmacology.
  doi: 10.1016/j.neuropharm.2012.06.005
– volume: 144
  year: 2019
  ident: 47117_CR3
  publication-title: Pediatrics
  doi: 10.1542/peds.2019-2528
– volume: 53
  start-page: 184
  year: 2003
  ident: 47117_CR17
  publication-title: Biol. Psychiatry.
  doi: 10.1016/S0006-3223(02)01401-4
– volume: 55
  start-page: 43
  year: 2016
  ident: 47117_CR46
  publication-title: Alcohol.
  doi: 10.1016/j.alcohol.2015.10.005
– volume: 66
  start-page: 87
  year: 2008
  ident: 47117_CR67
  publication-title: Hum. Hered.
  doi: 10.1159/000119108
– volume: 5
  start-page: 727
  year: 2018
  ident: 47117_CR9
  publication-title: Lancet Psychiatry.
  doi: 10.1016/S2215-0366(18)30269-4
– volume: 140
  start-page: 1
  year: 2003
  ident: 47117_CR26
  publication-title: Behav. Brain. Res.
  doi: 10.1016/S0166-4328(02)00272-3
– volume: 24
  start-page: 223
  year: 2014
  ident: 47117_CR40
  publication-title: J. Child. Adolesc. Psychopharmacol.
  doi: 10.1089/cap.2013.0079
– volume: 2
  start-page: 65
  year: 2011
  ident: 47117_CR38
  publication-title: Front. Psychiatry.
  doi: 10.3389/fpsyt.2011.00065
– volume-title: Diagnostic and Statistical Manual of Mental Disorders
  year: 2013
  ident: 47117_CR1
  doi: 10.1176/appi.books.9780890425596
– volume: 6
  start-page: 203
  year: 2013
  ident: 47117_CR23
  publication-title: BMC Res. Notes
  doi: 10.1186/1756-0500-6-203
– volume: 3
  start-page: 555
  year: 2016
  ident: 47117_CR8
  publication-title: Lancet Psychiatry.
  doi: 10.1016/S2215-0366(16)00096-1
– volume: 760
  year: 2021
  ident: 47117_CR12
  publication-title: Neurosci. Lett.
  doi: 10.1016/j.neulet.2021.136086
– volume: 169
  start-page: 186
  year: 2012
  ident: 47117_CR30
  publication-title: Am. J. Psychiatry
  doi: 10.1176/appi.ajp.2011.11040551
SSID ssj0000529419
Score 2.4088857
Snippet Attention deficit hyperactivity disorder (ADHD), a childhood-onset neurobehavioral disorder, often perturbs scholastic achievement and peer-relationship. The...
Abstract Attention deficit hyperactivity disorder (ADHD), a childhood-onset neurobehavioral disorder, often perturbs scholastic achievement and...
SourceID doaj
proquest
crossref
springer
SourceType Open Website
Aggregation Database
Index Database
Publisher
StartPage 19922
SubjectTerms 631/208
631/337
631/378
631/61
692/308
692/4017
692/53
692/699
Attention deficit hyperactivity disorder
Children
Gene expression
Genetic diversity
Genetic variance
Genotypes
Glutamate receptors
Glutamatergic transmission
Humanities and Social Sciences
Methylphenidate
multidisciplinary
Peripheral blood
Science
Science (multidisciplinary)
SummonAdditionalLinks – databaseName: DOAJ Open Access Full Text
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA6yIHgRn1hdZQRvWuwjaZOjr3UV9KTgLaRpKoJ0ZR-C_8Ef7Uzarg8QL54Wuu2S5pudmS_JfMPYQVxVieEZSV8mecidQD9oRRYKF1lJtZlVQYXCN7fZ8J5fP4iHL62-6ExYIw_cTNwxz02cl4WShVQ8z60UUZE5ZbmLVCKrirwvxrwvZKpR9U4Uj1VbJROl8niCkYqqyZI0RH-Mrll8i0ResP9blvljY9THm8EKW24TRThpBrjKFly9xhab1pFv6-z9Ek3GYLrpAH2We0HqDGgLVJIIr8h_6XgLGH9Yw5VAcsZeP-AZHrvnxujzYEqhCqGmNTMwdQnzg-eAZB1hL-HJLzv4VUQYVXBVk0XByfnwHKgbDZUKb7D7wcXd2TBsOyuEFoPWNLRVZpArpJmzfqc2T6k1FRdGxGXuZCTKCDGUVtpCKStL5DyUV8aqKE1OSccm69Wj2m0xwPfAnMtlSLQs5w4_TJyarFKFchLJV8AOu1nWL42AhvYb36nUDSYaMdEeEy0CdkpAzO8k8Wt_AU1Ctyah_zKJgPU7GHX7j5zoREolicDxgO3Pv8YJpg0SU7vRjO5RGNBJsTBgRx38nz_x-7C3_2PYO2yJetlToWPM-6w3Hc_cLmY802LPG_cH5U38mQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwEB5RUKVeENBWDS8NUm9t2jzsxD4gxHtbiZ66EjfLcRxUCWXpsiD4D_xoZpxkKyrgFCmx8_BMZuaz_c0AfE6bJrOi4NSXWRkLL8kOOlnE0idOMTezqZgofParGI3Fz3N5vgBDuaN-AK-fhXZcT2o8vfx29_d-j3743Y4yrr5fkxNioliWx2RqyerKN7BEnqnkigZnfbjf5frOtEh1z515vusT_xTS-D-JPf9bLg1e6GQFlvvwEfc7ea_Cgm_X4G1XUPL-PTyckiJZCkI9kiXzVwSokTSEiYp4S6iYN72gDVs4fI2c5DhkFbjEi6HflCwhztiBkQLwTBratsb5dnQkCE_KUOOfMBkR5hZx0uCPlvUM949GR8g1aphA_AHGJ8e_D0dxX28hduTKZrFrCksIIi-8C-u3Zc4Fq4S0Mq1LrxJZJyRZ5ZSrtHaqJiTE0Waqq9qWHIp8hMV20vpPgPQdFIn5guCXE8LTwaa5LRpdaa8IkkXwZRhlc9Wl1TBhOTxXppOJIZmYIBMjIzhgQcxbckrscGIyvTD9H0ZtbVrWlVaV0qIsnZJJVXjthE90ppomgs1BjGZQM5MppRXDOhHBzvwyDTAvm9jWT264jSY3z3kMI_g6iP_fLV5-7fXXn7gB77h2PRMbU7EJi7Ppjd-iCGdWbQe1fQSNw_dh
  priority: 102
  providerName: Scholars Portal
– databaseName: Springer Nature HAS Fully OA
  dbid: AAJSJ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LT9tAEB5RIqReEG2pagjVVOJWrPqxa-8ewzONVC4tErfVer1GSMiJQkDiP_CjmdnYQSB64GQpXluOv_E8dma-AdhPmyazomDqy6yMhZekB50sYukTp7g3s6m4UfjPeTG-EJNLebkGWd8LE4r2A6VlUNN9ddivWzI03AyW5TGpU9Ks8gMMmKqdZHswGk3-TlY7K5y7EqnuOmSSXL1x8QsrFMj6X3iYr5KiwdacbsFm5yTiaPlYn2DNt59hYzk28uELPJ6RuFhyNT2SvvIzCpuR5IDbEfGeYl8ubUEbCjV8jUxlHLgDbvCqv25O-g4XbKYIZt4vQ9vWuCo6RwrUCfIar8OWQ9hBxGmDv1uWJhwdj4-RJ9Fwm_A2XJye_Dsax91UhdiRwVrEriksxQl54V3I0pY5j6US0sq0Lr1KZJ0QfsopV2ntVE3xDvuUqa5qW7LD8RXW22nrvwHS_yB_yxcUZDkhPB1smtui0ZX2igKvCH72b9nMluQZJiS9c2WWmBjCxARMjIzgkIFYrWTi6_DDdH5lOkGgtTYt60qrSmlRlk7JpCq8dsInOlNNE8Gwh9F0X-OtyZTSioM3EcGP1Wl6wZwcsa2f3vEaTcac2QojOOjhf77F_x97533Ld-EjT6zndsZUDGF9Mb_ze-TXLKrvnSA_AQaP81Q
  priority: 102
  providerName: Springer Nature
Title Glutamate receptor genetic variants affected peripheral glutamatergic transmission and treatment induced improvement of Indian ADHD probands
URI https://link.springer.com/article/10.1038/s41598-023-47117-5
https://www.proquest.com/docview/2889800864
https://www.proquest.com/docview/2890361700
https://doaj.org/article/47a17db98b89477c850b6e9c4e0928ff
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ba9RAFD5oi-BLsV4wtl1G8E1Dc5nrk2y3retCi6iFfRsmk0kRJFl3t4L_oT-658wmWyroSwLJ5DbfybnOOQfgXd40heOSSl8WKuVBIB_0QqYiZF5TbmZTUaLwxaWcXvHZXMx7h9uqX1Y58MTIqOvOk4_8uNDaaFLA-cfFr5S6RlF0tW-h8Rh2qXQZUbWaq62PhaJYPDd9rkxW6uMVyivKKSvKFLkyMmjxQB7Fsv0PdM2_wqNR6pw_g71eXWTjDb778Ci0z-HJpoHknxdw-wkJx6HSGRhyrrBAA5ohRVBiIvuNVjAtcmEuLtkINaOixrGKwE92PVy3RM7H1iSwEHDynDHX1my7_JyhyY7g1-xHdD5EXyLrGva5Jbpi49PpKaOeNJQw_BKuzs--T6Zp318h9Si61qlvpEOLoZTBx3itKqlBFRdO5LUKOhN1hkhqr31ljNc1Wj6kXeamqp0i1eMV7LRdG14Dw-9AzStINLc85wF3Li-dbExlgkYTLIH3wyzbxaaMho3h71LbDSYWMbEREysSOCEgtiOpBHY80C2vbf9H4ViXq7oyutKGK-W1yCoZjOchM4VumgQOBxht_1-u7D0VJfB2exonmMIkrg3dDY0xKNapbmECHwb472_x79d-8_8nHsBT6lVPiYw5P4Sd9fImHKFGs65GkWxHsDsez77NcH9ydvnlKx6dyMkoeglwe8H1HRp_-g8
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VIgQXVF6qocAiwQms-rFr7x4q1BJKQh-nVsptWe-uq0rIDkkK6n_gt_AbO7O2UxUJbj1FSjaOs_N55pudF8DbtK4zwwtqfZmVMfcC9aAVRSx8YiXVZtYVFQofHRfjU_51KqZr8GeohaG0ykEnBkXtWktn5NuZlEoSAecfZz9imhpF0dVhhEYHiwN_-QtdtsXOZITyfZdl-59PPo3jfqpAbFFhL2NbFwZ5cl54G6KUZU5jmbgwInWll4lwCd6_tNJWSlnpkO8Tp0pV5UxJBhevewfuouFNyNkrp-XqTIeiZjxVfW1OksvtBdpHqmHL8hitABoEccP-hTEBN7jtX-HYYOX2N-BhT0_ZboenR7Dmm8dwrxtYefkEfn9BoBokuZ6hpvQzdNgZIpAKIdlP9LopqYaZkCLiHaMmyqFrwXd2NnxvjpqWLclAIsDopI6ZxrFVujs7bxyCzbHzcNgRzi5ZW7NJQzhmu6PxiNEMHCpQfgqnt7Lzz2C9aRu_CQz_BzI9X6B7Zzn3-GLS3BS1qpSX6PJF8H7YZT3r2nboEG7Ppe5kolEmOshEiwj2SBCrldRyO7zRzs90_wTjWpOWrlKykoqXpZUiqQqvLPeJymRdR7A1iFH3emChr1EbwZvVx7jBFJYxjW8vaI1CGkF9EiP4MIj_-hL_vu3n___F13B_fHJ0qA8nxwcv4EFGIKT8Rb4F68v5hX-JbGpZvQoQZvDttp-ZK-0_Lvc
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTiBeEJ8iMMBI8ARR82En9gNCG11pGVQTYtLejGM70ySUlLYD7X_gL-Kv485NOg0J3vZUKXWTxne--903wIu0rjPDC2p9mZUx9wLloBVFLHxiJdVm1hUVCn-aFZMj_uFYHG_B774WhtIqe5kYBLVrLfnIh5mUShIA58O6S4s4HI3fzr_HNEGKIq39OI01ixz4859ovi3fTEdI65dZNt7_8m4SdxMGYovCexXbujCImfPC2xCxLHMa0cSFEakrvUyES_BdpJW2UspKh9if8FWqKmdKUr5432uwXZJVNIDtvf3Z4eeNh4diaDxVXaVOksvhErUlVbRleYw6AdWDuKQNw9CAS0j3r-Bs0Hnj23CrA6tsd81dd2DLN3fh-np85fk9-PUe2dYg5PUM5aafo_nOkB-pLJL9QBucUmyYCQkj3jFqqRx6GHxjJ_3vFih32YrUJbIb-e2YaRzbJL-z08Yh6zl2GlwfwZPJ2ppNG-JqtjuajBhNxKFy5ftwdCV7_wAGTdv4h8DwPRD3-QKNPcu5xw-T5qaoVaW8RAMwglf9Luv5uomHDsH3XOo1TTTSRAeaaBHBHhFis5IacIcL7eJEd-cZ15q0dJWSlVS8LK0USVV4ZblPVCbrOoKdnoy6kwpLfcHDETzffI0bTEEa0_j2jNYoBBXUNTGC1z35L27x77_96P9PfAY38Lzoj9PZwWO4mREPUjIj34HBanHmnyC0WlVPOx5m8PWqj80fSfg0kg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Glutamate+receptor+genetic+variants+affected+peripheral+glutamatergic+transmission+and+treatment+induced+improvement+of+Indian+ADHD+probands&rft.jtitle=Scientific+reports&rft.au=Chatterjee%2C+Mahasweta&rft.au=Saha%2C+Sharmistha&rft.au=Shom%2C+Sayanti&rft.au=Dutta%2C+Nilanjana&rft.date=2023-11-14&rft.pub=Nature+Publishing+Group&rft.eissn=2045-2322&rft.volume=13&rft.issue=1&rft.spage=19922&rft_id=info:doi/10.1038%2Fs41598-023-47117-5&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon